Development and Validation of UV Spectrophotometric Method for Estimation of Cyproheptadine hydrochloride
Prof. Sushil D. Patil*, Tejashri Dugaje*, Dr. Sanjay J. Kshirsagar
MET’s Institute of Pharmacy, MET League of Colleges, Bhujbal Knowledge City, Adgaon, Nashik,
Savitribai Phule Pune University, Maharashtra, India
*Corresponding Author E-mail: sushilpharma@rediffmail.com
ABSTRACT:
1.1 Cyproheptadine hydrochloride:
Cyproheptadine hydrochloride(CYP) chemically known as 4-(5H dibenzo[a,d]-cyclohepten-5-ylidene)-1-methyl-piperidine HCl. Cyproheptadine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose,itching eyes/nose, sneezing , hives, and itching. It works by blocking a certain natural substance(histamine) that our body makes during an allergic reaction. This medication also blocks another natural substance in your body(serotonin).
This medication should not be used in newborn or premature infants. Cyproheptadine hydrochloride is a serotonin antagonist and histamine H1 blocker used as antipruitic, appetite stimulant, antiallergic and for the post-gastrectomy dumping syndrome etc. Cyproheptadine HCl is the hydrochloride salt of synthetic methyl–piperidine derivative with antihistaminic and the antiserotoninergic properties.
Cyproheptadine exhibits anticholinergic andsedative properties and has been shown to stimulate appetite and weight gain.Cyproheptadine hydrochloride (anhydrous) is the hydrochloride salt of cyproheptadine.[3] There were many analytical method performed of cyproheptadine hydrochloride such as HPLC [10],extraction and determination of CPHin human urine by DLLME-HPLC method [7],quantification of CPH in human plasma by HPLC coupled to electrospray tandem mass spectrometry in bioequivalence study [17], stability indicating HPLC method [16], first derivative synchronous spectrofluorimetric method [15],ion association titration[9], spectroscopic method[2], Isocratic HPLC method for the Quantitation of cyproheptadine in human milk and plasma using solvent and solid phase extraction techniques [18],etc., In “Development and validation of UV-spectrophotometric method for estimation of cyproheptadine hydrochloride in bulk and tablet formulation by co-solvency approach” water and methanol used[1] but we developed another UV method in which only distilled water used as solvent which more economical and safe to use.
1.2 Drug profile-
Fig1: Structure of cyproheptadine hydrochloride
2. MATERIAL AND METHODS:
2.1 Apparatus and Equipments:
A Shimadzu UV-Visible spectrophotometer (UV-1800 Shimadzu Corporation, Kyoto, Japan) was used for all absorbance measurements with 1 cm paired quartz cell.
2.2 Reagents and Chemicals:
Pharmaceutical grade cyproheptadine hydrochloride was supplied as a gift sample from Raptakos, Brettand Co. Ltd, Thane, India. Distilled water used as solvent.
2.3 Preparation of standard stock solution:(100ug/ml)
An accurately weighed quantity of 10mg cyproheptadine HCl was transferred to 100 ml volumetric flask dissolved with 50 ml of distilled water and sonicated for 10 min ,volume was then made up to the mark with same distilled water.
2.4 Selection of wavelength for analysis:
Prepared appropriate dilution of standard stock solution and solution containing 10ug/ml of cyproheptadine hydrochloride, these dilution solutions were scanned in range 200-400 nm.Drug showed λmax at 286nm in (Fig 2).
Fig 2: UV spectra of cyproheptadine hydrochloride(CPH)
2.5 METHOD VALIDATION:
The UV Spectrophotometric method was validated as per ICH guidelines for method validation. The performance parameters like linearity, precision, and accuracy were evaluated.[5]
1. Limit of detection (LOD):
LOD is the lowest level of concentration of analyte in a sample that can be detected, though not necessarily quantitated. It was calculated by using the formula,[4,5]
LOD=
Where,
=standard deviation of the response
S=slope of calibration curve.
2. Limit of Quantitation(LOQ):
LOQ is the lowest concentration of analyte in a sample that may be determined with acceptable accuracy and precision when the required procedure is applied. It was calculated by using the formula,[5]
LOQ=
Where,
standard deviation of the respose
S=slope of calibration curve.
3. Linearity:
Linearity was studied by diluting standard stock solution of cyproheptadine HCl 2-10 ug/ml concentrations (n=3).Calibration curve with concentrations verses absorbance were plotted at their respective wavelengths and the obtained data was subjected to regression analysis using the least square method. The standard curve of drug showed in (fig 2).[4]
Table1: calibration study data of cyproheptadine HCl(CPH)
Sr.No. |
Concentration(ug/ml) |
Absorbance at 286nm |
1 |
2 |
0.053 |
2 |
4 |
0.115 |
3 |
6 |
0.184 |
4 |
8 |
0.240 |
5 |
10 |
0.305 |
Fig 3: Calibration curve of cyproheptadine hydrochloride (2-10ug/ml)
4. Specificity:
Specificity is ability to measure unequivocally the desired analyte in the presence of components such as excipient and impurities. For specificity determination, lactose monohydrate was used as excipient and from which is prepared stock solution (B) (100ug/ml).Spiking Lactose monohydrate in 3 different levels 80,100,120 % respectively from the stock solution (B) and the stock solution (A) which is spike 100% and mix with 3 different level of lactose monohydrate solution to determine the amount of % recovery at 286nm.[4,5]
5. Accuracy:
To check the accuracy of the developed methods and to study interference of formulation additives, analytical recovery experiments were carried out by using standard addition method. Reference standard solution of each drug was added to tablet samples at three different concentrations level (80,100,120%). At each level, samples were prepared in triplicate and the mean percentage recoveries and percentage RSD value were calculated.[4,5]
6. Precision:
Precision is the degree of agreement among individual test results when the procedure is applied repeatedly to multiple samplings. It was determined by studying repeatability, intra-day and inter-day precision of method. The average recovery of the analyte of 80,100,120 % solution of standard stock solution. For intraday, the analysis was carried out at different intervals on the same day and for inter day, the analysis was carried on different days.[4,5]
Table2: Percentage recovery studies for specificity of CPH
Sr. No. |
Conc.API(ug/ml) |
Add % level |
Spike stock(ug/ml) |
Abs. at 286nm |
Drug found |
% Recovery |
1. |
6 |
80 |
4.8 |
0.191 |
5.72 |
95.33 |
2. |
6 |
100 |
6 |
0.189 |
5.78 |
96.33 |
3. |
6 |
120 |
7.2 |
0.200 |
6.08 |
100.9 |
Table 3: Accuracy study data (plane API +Product)
Sr.No. |
API(A) (ug/ml) |
Add% level |
API(B) (ug/ml) |
Abs. at 286nm |
Conc. found for both (A+B) |
% Recovery |
Avg.% Recovery |
Standard deviation |
1. |
6 |
80 |
4.8 |
0.306 |
9.449045 |
87.49115 |
|
|
2. |
6 |
80 |
4.8 |
0.306 |
9.449045 |
87.49115 |
87.68774 |
0.278016 |
3. |
6 |
80 |
4.8 |
0.308 |
9.512739 |
88.08092 |
|
|
4. |
6 |
100 |
6 |
0.359 |
11.13694 |
92.80786 |
|
|
5. |
6 |
100 |
6 |
0.36 |
11.16879 |
93.07325 |
|
|
6. |
6 |
100 |
6 |
0.362 |
11.23248 |
93.60403 |
93.16171 |
0.331003 |
7. |
6 |
120 |
7.2 |
0.395 |
12.28344 |
93.05636 |
|
|
8. |
6 |
120 |
7.2 |
0.395 |
12.28344 |
93.05636 |
92.97594 |
0.113734 |
9. |
6 |
120 |
7.2 |
0.394 |
12.25159 |
92.81509 |
|
|
Table 4: Precision study data for CPH
Sample No. |
Intra-day (%Assay) |
Inter -day (%Assay) |
1 |
102.9611 |
102.9873 |
2 |
103.9735 |
101.4572 |
3 |
102.0273 |
100.335 |
Mean |
102.9873 |
101.5932 |
SD |
1.36721 |
1.383102 |
%RSD |
1.335226 |
1.366404 |
Robustness:
Robustness of the proposed method is determined by analysis of aliquots from homogenous slots by different analysts using similar operational and environmental conditions. [4,5]
Table 5: Robustness study data for CPH
Sample no. |
|
Wavelength (nm) |
|
|
285nm |
282nm |
290nm |
1. |
101.2208 |
98.56688 |
98.03609 |
2. |
102.8132 |
100.1592 |
99.62845 |
3. |
103.8747 |
101.7516 |
101.2208 |
Avg. % Recovery |
102.6362 |
100.1592 |
99.62845 |
SD |
1.335781 |
1.300154 |
1.300154 |
% RSD |
1.301471 |
1.298087 |
1.305003 |
3. RESULT AND DISCUSSION:
Development and optimization of UV-spectrophotometric method:
The UV-spectrophotometric method was developed for quantitative determination of cyproheptadine hydrochloride. For that selection of proper wavelength depends upon the nature of the sample and its solubility parameter. For the proper result different trials with different diluents concentration were performed and best result obtained which used for quantitative estimation of drug.
Selection of wavelength by scanning standard stock solution in UV -spectrophotometric between 200 nm to 400nm on spectrum mode, using distilled water as a blank. Cyproheptadine hydrochloride shows λmax at 286nm.
Method validation:
According to ICH guideline validation parameter was performed. The following result were obtained.
Table 6: Summary of various validation parameters
Sr.No. |
Parameter |
Result |
1. |
λmax |
286nm |
2. |
Slope |
0.0314 |
3. |
Intercept |
0.0093 |
4. |
Linearity and range (ug/ml) |
2-10 ug/ml |
5. |
Accuracy (% recovery) |
91.27513 |
6. |
Precision (% RSD) Interday precision (n=3) Intraday precision(n=3) |
RSD<2% 1.335226 1.366404 |
7. |
Limit Of Detection Limit Of Quantitation |
0.013471μg/ml 0.040822μg/ml |
4. CONCLUSION:
The developed UV methods were found to be more accurate, precise and reproducible. This validation parameter of these methods shows good results. The recovery studies revealed excellent accuracy and high precision of the method. The methods were found to be simple, safe and economical. These methods could be applied for routine analysis in quality control laboratories and also it will useful in stability study of drug by using UV spectrophotometric method.
5. ACKNOWLEDGMENT:
The authors are thankful to the management and trustees of Mumbai Educational Trust’s Bhujbal Knowledge City, Nashik, for providing necessary chemicals and analytical facilities and to Raptakos, Brett and Co. Ltd, Thane, India. gift sample.
6. REFERENCE:
1. Madhu M, Chanti Naik M, Gireesh Kumar E, Chand Basha S, Gopinath.C Development and validation of spectroscopic method for the estimation of cyproheptadine HCl in tablet dosage form Journal of Global Trends in Pharmaceutical Sciences,2016,2982-2986.
2. Wagh Yogesh B., Bhushan Bhairav A., and Saudagar Ravindra B.”Development and validation of UV-spectrophotometric method for estimation of cyproheptadine hydrochloride in bulk and tablet formulation by co-solvency approach”, World Journal of Pharmaceutical Research, Volume 5, 1924-1930.
3. Cyproheptadine hydrochloride, available on website of WebMD.
4. ICH Harmonized Triplicate Guidelines, “Validation of analytical procedures: text and methodology, Q2 (R1),” in International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005.
5. International Conference of Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Methodology, Adopted in Geneva 1996.
6. Indian Pharmacopoeia 2014, volume 2, Published by the Indian Pharmacopoeia commission Ghaziabad 1st January 2014, 1489-1491.
7. Mehdi Mahama, Vahid Kiarostamib, Syed Waqif-Husaina, et al., ”Extraction and determination of cyproheptadine in human urine by DLLME-HPLC Method.”Iranian Journal of pharmaceutical Research 2013,12:2,311-318.
8. Alaa El-Gindy, Fawzy El-Yazby, Ahmed Mostafa, Moustafa M. Maher, "HPLC and chemometric methods for the simultaneous determination of cyproheptadine hydrochloride, multivitamins, and sorbic acid",Journal of Pharmaceutical and Biomedical Analysis 2004, 35,703–713.
9. Madihalli S. Raghu and Kanakapura Basavaiah, Application of Ion-Association Titration for the Assay of Cyproheptadine Hydrochloride in Pharmaceuticals”. International Scholarly Research Network, (ISRN Analytical Chemistry) Volume 2012, 1-7.
10. Burrows GW, Alliger CL, High-performance liquid chromatographic determination of cyproheptadine hydrochloride in tablet formulations", J Pham Sci.1983;72(10):1212-3.
11. Madihalli S. Raghu and Kanakapura Basavaiah, Sensitive and selective methods for the determination of cyproheptadine in tablets using N-Bromosucinimide and two dyes", Association of the chemical Engineering of serbia (AchE), (Chemical industry and chemical Engineering Quarterly 2012, 18 (3), 449-458.
12. Sayana, T. Veeraiah and Ch. Venkata Ramana Reddy, Determination of cyproheptadine hydrochloride in pure and pharmaceutical forms:A Spectrophotometric study. Oriental journal of chemistry, 31,2231-5039.
13. Xesus Feasab, Lei Yeb Development and validation of LC–MS/MS method for the determination of cyproheptadine in several pharmaceutical syrup formulations."Journal of Pharmaceutical and Biomedical Analysis, 2009, 50:5, 1044-1049.
14. Kanakapura Basavaiah and, Vaidyanathan Shakunthala Charan, Ion-Pair Complexometric determination of cyproheptadine hydrochloride using Bromophenol Blue. Science Asia 2004, 30,163-170.
15. Fathy M. Salama, Khalid, A.M. Attia, Ragad A.M. Said, Ahmed EI-Olemy, et al. First derivative synchronous spectrofluorimetric determination of cyproheptadine hydrochloride in presence of its oxidative degradation product at critical micelle concentration.” Journal of Advanced pharmacy Research, 2018, 2:2,104-112.
16. M.K. Sharaf El-Din, F. Belal, M.M. Tolbaand H. Elmansi, Stability indicating HPLC Method Coupled with Fluorescence Detection for the Determination of Cyproheptadine Hydro-chloride in Its Tablets Studies on Degradation Kinetics. Analytical Chemistry Letters, 2018, 8:4, 565-577.
17. Gustavo Duarte Mendesa, Andre Arrudaa, Lu Shi Chenb, Jose Cassio de Almeida Magalhaesa, Khalid M Alkharfyd and Gilberto De Nuccia, Quantification of cyproheptadine in human plasma by high‐performance liquid chromatography coupled to electro spray tandem mass spectrometry in abioequivalence study.Biomed. Chromatography. 2012; 26: 129–136.
18. John E. Koundourellis, Kenneth O. Ebeteand Eleftheria T. Malliou, Isocratic high performance liquid chromatographic method for the quantitation of cyproheptadine in human milk and plasma using solvent and solid phase extraction techniques. Journal of Liquid Chromatography and Related Technologies, 22:4, 603-614.
Received on 14.02.2019 Modified on 05.03.2019
Accepted on 25.03.2019 ©AJRC All right reserved
Asian J. Research Chem. 2019; 12(2):112-115.
DOI: 10.5958/0974-4150.2019.00024.5